Prabhakaran Gopalakrishnan is a Cardiology physician affiliated with Aultman Hospital. OpenAlex indexes 64 publications with 286 citations (h-index 8); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2600 Sixth St SW Ste 710
Canton, OH 447101702
Telephone
330-454-8076Registry record last updated 7 Oct 2019.
Clinical trials
- Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
Sponsor: Aultman Health Foundation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20256 payments
- Abbott LaboratoriesProgram year20258 payments
- Edwards Lifesciences CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.7%Beta blocker18.5%Metoprolol Succinate60%Carvedilol24%Metoprolol Tartrate11%Sotalol4%Atenolol2%Part D<11 patientsStatin10.3%Atorvastatin Calcium63%Rosuvastatin Calcium32%Simvastatin2%Pravastatin Sodium2%Part D<11 patients+ 17 more classes in this area
Blood & clotting
8.1%Factor Xa inhibitor5.4%Eliquis87%Xarelto13%Part D≥82 patientsP2Y12 inhibitor2.7%Clopidogrel100%Part D≥50 patientsMetabolism & gastrointestinal
7.7%Potassium supplement4.5%Potassium Chloride100%Part D≥90 patientsSGLT2 inhibitor2.7%Jardiance100%Part D≥47 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-16168-ACC THE LATE BLOOMER: WHEN A LIFELONG PFO BECOMES SYMPTOMATIC
Journal of the American College of Cardiology
2026 - 26-CCC-18061-ACC THE UNFAITHFUL 7000: FIRST REPORTED CASE OF CORONARY ARTERY CALCIUM SCORE ABOVE 7000
Journal of the American College of Cardiology
2026 - TRANSCATHETER ASD CLOSURE: REDEFINING TREATMENT STRATEGY IN ISCHEMIC CARDIOMYOPATHY
Journal of the American College of Cardiology
2025 - CMR for the Evaluation of Myocardial Infarction with Unobstructed Coronaries: How Early Is Too Early?
Journal of Cardiovascular Magnetic Resonance
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ohad Ziv
Aultman Hospital
Brendan Duffy, MD
Aultman Hospital
Michael Krew, MD
Aultman Hospital
Adarsh Vennepureddy, MD
Aultman Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”